Impaired endothelial function, autoantibodies to endothelial cells, type I Interferon (IFN) activity and neutrophil extracellular traps have been all proposed as potential culprits in autoimmune disease-related atherosclerosis. This evidence concerns the gene IFNA1 and atherosclerosis.